These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11074875)

  • 21. Phenelzine versus imipramine for atypical depression.
    Nakdimen KA
    Am J Psychiatry; 1988 Oct; 145(10):1322. PubMed ID: 3421370
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive therapy and pharmacotherapy for depression. Singly and in combination.
    Hollon SD; DeRubeis RJ; Evans MD; Wiemer MJ; Garvey MJ; Grove WM; Tuason VB
    Arch Gen Psychiatry; 1992 Oct; 49(10):774-81. PubMed ID: 1417429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive behavior therapy for depression? Choose horses for courses.
    Parker G; Roy K; Eyers K
    Am J Psychiatry; 2003 May; 160(5):825-34. PubMed ID: 12727682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive-behavioral management of drug-resistant major depressive disorder.
    Fava GA; Savron G; Grandi S; Rafanelli C
    J Clin Psychiatry; 1997 Jun; 58(6):278-82; quiz 283-4. PubMed ID: 9228899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why the Hamilton Depression Rating Scale endures.
    Bech P; Engelhardt N; Evans KR; Gibertini M; Kalali AH; Kobak KA; Lipsitz JD; Williams JB; Pearson JD; Rothman M
    Am J Psychiatry; 2005 Dec; 162(12):2396; author reply 2397-8. PubMed ID: 16330618
    [No Abstract]   [Full Text] [Related]  

  • 29. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why the Hamilton Depression Rating Scale endures.
    Corruble E; Hardy P
    Am J Psychiatry; 2005 Dec; 162(12):2394; author reply 2397-8. PubMed ID: 16330615
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings.
    Fava GA; Rafanelli C; Grandi S; Conti S; Belluardo P
    Arch Gen Psychiatry; 1998 Sep; 55(9):816-20. PubMed ID: 9736008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why the Hamilton Depression Rating Scale endures.
    Hsieh CL; Hsieh CH
    Am J Psychiatry; 2005 Dec; 162(12):2395; author reply 2397-8. PubMed ID: 16330617
    [No Abstract]   [Full Text] [Related]  

  • 34. Type II error and antidepressants.
    Walker JB; Klein RM; Yee SL
    J Clin Psychiatry; 2001 May; 62(5):373-5. PubMed ID: 11411822
    [No Abstract]   [Full Text] [Related]  

  • 35. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
    Gelernter CS; Uhde TW; Cimbolic P; Arnkoff DB; Vittone BJ; Tancer ME; Bartko JJ
    Arch Gen Psychiatry; 1991 Oct; 48(10):938-45. PubMed ID: 1929764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Stain R; Wasserman D
    Lakartidningen; 2019 Jan; 116():. PubMed ID: 30644995
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete remission of 'treatment resistant' severe melancholia in adolescents with phenelzine: two case reports.
    Strober M; Pataki C; DeAntonio M
    J Affect Disord; 1998 Jul; 50(1):55-8. PubMed ID: 9716281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study.
    Albus M; Scheibe G
    Am J Psychiatry; 1993 Dec; 150(12):1878-80. PubMed ID: 8238647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.